|Articles|March 5, 2015

EFGCP Postpones Barcelona Meeting on Geriatric Trials

The European Forum for GCP has postponed its multi-stakeholder workshop about “Excluded Older People from Clinical Research,” which was due to be held on 24 March at the Faculty of Medicine/Hospital Clínic de Barcelona, Spain.

The meeting was being organized by the EFGCP Geriatric Medicines Working Party in partnership with the Barcelona institution. Read more here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

© putilov_denis - © putilov_denis - stock.adobe.com

November 3rd, 2026

From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA

Neuroscience trials struggle to show benefit because symptoms are subjective and variable, and eCOA strengthens dossiers by standardizing ClinRO administration, capturing outcomes in real time to reduce recall bias, and adding patient and caregiver perspectives that clinician scales miss.

© flashmovie - © flashmovie - stock.adobe.com

November 3rd, 2026

Beyond the Modernization Act: What It Takes to Make Community Research Infrastructure Permanent

Community participation gaps look less like a question of patient willingness and more like a financing and infrastructure problem that no single bill has yet solved.

November 3rd, 2026

ACT Brief: Embedding AI Across Operations, Faster Trial Decisions, and Voceryq Approval

In today’s ACT Brief, we examine what changes when AI is embedded across clinical operations, why faster trial data isn’t yet producing faster decisions, and how FDA granted accelerated approval to a therapy for a rare airway disease.

© Sergey Nivens - © Sergey Nivens - stock.adobe.com

November 2nd, 2026

From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions

Data capture is no longer the bottleneck, and whether the lag between a signal and a decision shrinks depends on signal design, AI governance, and vendor orchestration.

November 2nd, 2026

Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health

In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses what changes when AI is embedded across protocol strategy, data infrastructure, and workflow tools at once, where governance frameworks tend to fall short, and why CROs must orchestrate AI ecosystems rather than simply aggregate them.

November 2nd, 2026

ACT Brief: Community Research Policy Needs, Walmart Trial Centers, and Psoriatic Arthritis Approval

In today’s ACT Brief, we examine what policy changes would help community and rural institutions join research, how Walmart is expanding clinical trial centers into three more states, and how FDA approved Ilumya for adults with active psoriatic arthritis.

© peshkova - © peshkova - stock.adobe.com

October 30th, 2026

Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas

The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.

October 30th, 2026

What Needs to Happen Beyond the Clinical Trial Modernization Act

In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.

EFGCP Postpones Barcelona Meeting on Geriatric Trials

Related to this article

Trending on Applied Clinical Trials Online

From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions

Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health

Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas

ACT Brief: Embedding AI Across Operations, Faster Trial Decisions, and Voceryq Approval

Beyond the Modernization Act: What It Takes to Make Community Research Infrastructure Permanent